# Eurofins BioPharma Product Testing ENCO Inc. - Inspection Records

Source: https://www.keypedia.com/companies/eurofins-biopharma-product-testing-enco-inc/019572ed-c582-4981-86a3-185cedcd073f

> Inspection records and compliance data for Eurofins BioPharma Product Testing ENCO Inc. in Cary, North Carolina. Access full analysis and detailed observations.

---

## Details

- Name: Eurofins BioPharma Product Testing ENCO Inc.
- FEI Number: 3009827154
- City: Cary
- State: North Carolina
- Country Name: United States
- Address Line 1: 102 Woodwinds Industrial Ct Ste E
- Zip Code: 27511
- Business Operations: API/FDF ANALYTICAL TESTING

## Related Documents

- [FDA Inspection 1279054 - Eurofins BioPharma Product Testing ENCO Inc. - 2025-08-01](https://www.keypedia.com/records/fda_inspections/eurofins-biopharma-product-testing-enco-inc/153aca8c-dfa4-4d8b-8269-dc55675e2576) — source: FDA, date: August 1, 2025
- [FDA Inspection 1279054 - Eurofins BioPharma Product Testing ENCO Inc. - 2025-08-01](https://www.keypedia.com/records/fda_inspections/eurofins-biopharma-product-testing-enco-inc/e39b6fe7-adfe-4cd5-8961-8d89ab8e3628) — classification: No Action Indicated (NAI), source: FDA, date: August 1, 2025
- [FDA Inspection 1041344 - Eurofins BioPharma Product Testing ENCO Inc. - 2018-01-12](https://www.keypedia.com/records/fda_inspections/eurofins-biopharma-product-testing-enco-inc/e40fdafa-e0b8-4656-888a-76cea9b07a80) — classification: No Action Indicated (NAI), source: FDA, date: January 12, 2018
- [FDA Inspection 889761 - Eurofins BioPharma Product Testing ENCO Inc. - 2014-07-11](https://www.keypedia.com/records/fda_inspections/eurofins-biopharma-product-testing-enco-inc/d239bc90-9209-4b66-bb23-2002e02d78be) — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 11, 2014
- [FDA Inspection 822786 - Eurofins BioPharma Product Testing ENCO Inc. - 2013-02-14](https://www.keypedia.com/records/fda_inspections/eurofins-biopharma-product-testing-enco-inc/cd7b345c-1360-404a-8def-5c26a7f34ac1) — classification: No Action Indicated (NAI), source: FDA, date: February 14, 2013

## Related Companies

- [Fougera Pharmaceuticals  Inc.](https://www.keypedia.com/companies/fougera-pharmaceuticals-inc/3868bd8e-22c5-4998-85b0-38e0df2d115b)
- [QualTech Laboratories, Inc.](https://www.keypedia.com/companies/qualtech-laboratories-inc/7cf9f443-ef52-4807-8a49-2322da5f4133)
- [R.D. Laboratories Inc.](https://www.keypedia.com/companies/rd-laboratories-inc/b75c7a7e-9454-4127-add6-6107232599f1)
- [SGS Institut Fresenius GmbH](https://www.keypedia.com/companies/sgs-institut-fresenius-gmbh/9053e3ca-148d-4280-ac0d-789a34084eb8)
- [Bionique Testing Laboratories LLC](https://www.keypedia.com/companies/bionique-testing-laboratories-llc/5ff35d77-a641-4c19-be01-51977e5fa9da)
- [Melbourn Scientific Limited (d.b.a. Intertek Melbourn)](https://www.keypedia.com/companies/melbourn-scientific-limited-dba-intertek-melbourn/4ba7ef03-9f18-4979-9a4a-174d60d4a57d)
- [Quinta Analytica s.r.o.](https://www.keypedia.com/companies/quinta-analytica-sro/f26231ff-818d-4ba0-b952-72115b356982)
- [Bioreliance Ltd.](https://www.keypedia.com/companies/bioreliance-ltd/0c15a584-09c6-4b3f-bb0e-5ac66b915aa1)
- [LabCorp Early Development Laboratories Limited.](https://www.keypedia.com/companies/labcorp-early-development-laboratories-limited/4f0ec845-b78a-440d-b747-30df285f57ad)
- [Access Business Group LLC](https://www.keypedia.com/companies/access-business-group-llc/382fe541-b50d-492a-8a2f-f9389e547bd1)